Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa

Despite the rapid expansion of antiretroviral therapy (ART) programmes, uptake of ART in pregnancy remains suboptimal. Little is known about the barriers to initiating lifelong ART in pregnancy and the challenges to postpartum retention in HIV care, particularly in sub-Saharan African contexts with a high burden of disease. In this qualitative study, 28 HIV-positive pregnant or postpartum women, who either had initiated ART or were eligible for ART, and 21 service providers were interviewed in Cape Town, South Africa, to investigate these barriers. Prevention of vertical transmission of HIV was often the primary motivation for starting treatment. Key challenges to ART initiation included late first presentation, denial of an HIV diagnosis, fear of disclosure, and treatment side-effects. The women expressed difficulties in accepting a lifelong commitment to treatment for maternal health benefit. Pregnant women who require ART face a triple burden of transitioning into pregnancy, accepting the HIV diagnosis, and recognising the urgent requirement to start lifelong ART before delivery. Focused interventions are required to address the psychosocial barriers to ART uptake and the linkages to care for pregnant HIV-positive women.

[1]  D. Bangsberg,et al.  Antiretroviral therapy refusal among newly diagnosed HIV-infected adults , 2011, AIDS.

[2]  R. Walensky,et al.  Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count. , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[3]  M. Newell,et al.  Prevention of mother‐to‐child transmission of HIV in resource‐rich and ‐poor settings , 2011, BJOG : an international journal of obstetrics and gynaecology.

[4]  L. Myer,et al.  Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. , 2010, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  L. Myer,et al.  Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa , 2010, Tropical medicine & international health : TM & IH.

[6]  T. Betancourt,et al.  Family-centred approaches to the prevention of mother to child transmission of HIV , 2010, Journal of the International AIDS Society.

[7]  L. Mofenson.  Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  E. Brown,et al.  Determinants of failure to access care in mothers referred to HIV treatment programs in Nairobi, Kenya , 2010, AIDS care.

[9]  J. Currier,et al.  Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa , 2010, Journal of acquired immune deficiency syndromes.

[10]  L. Myer,et al.  Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention , 2010, AIDS.

[11]  J. Stringer,et al.  Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation , 2010, AIDS.

[12]  T. Wild,et al.  Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda , 2010, Journal of the International AIDS Society.

[13]  A. Theron,et al.  HIV transmission from mother to child--HAART compared with dual therapy. , 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[14]  P. Msellati.  Improving mothers' access to PMTCT programs in West Africa: a public health perspective. , 2009, Social science & medicine.

[15]  A. Turner,et al.  Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience. , 2009, American journal of public health.

[16]  M. Nduna,et al.  Responding to Her Question: A Review of the Influence of Pregnancy on HIV Disease Progression in the Context of Expanded Access to HAART in Sub-Saharan Africa , 2009, AIDS and Behavior.

[17]  M. C. Canavarro,et al.  Relational contexts in adjustment to pregnancy of HIV-positive women: relationships, social support and personal adjustment , 2009, AIDS care.

[18]  T. Delvaux,et al.  Determinants of Nonadherence to a Single-Dose Nevirapine Regimen for the Prevention of Mother-to-Child HIV Transmission in Rwanda , 2009, Journal of acquired immune deficiency syndromes.

[19]  L. Sherr.  Vertical transmission of HIV – Pregnancy and Infant Issues , 2009 .

[20]  P. Stubblefield,et al.  The clinical content of preconception care: infectious diseases in preconception care. , 2008, American journal of obstetrics and gynecology.

[21]  M. Visser,et al.  Factors affecting disclosure in South African HIV-positive pregnant women. , 2008, AIDS patient care and STDs.

[22]  H. Rees,et al.  Safety and Efficacy of Initiating Highly Active Antiretroviral Therapy in an Integrated Antenatal and HIV Clinic in Johannesburg, South Africa , 2008, Journal of acquired immune deficiency syndromes.

[23]  V. Ehlers,et al.  Mothers' attitudes towards using services preventing mother-to-child HIV/AIDS transmission in Zimbabwe: an interview survey. , 2008, International journal of nursing studies.

[24]  M. Visser,et al.  To tell or not to tell: South African women's disclosure of HIV status during pregnancy , 2008, AIDS care.

[25]  F. Dabis,et al.  Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire , 2008, AIDS.

[26]  T. Jones.  Psychosocial Dimensions of HIV Infection in Pregnancy , 2008, Clinical obstetrics and gynecology.

[27]  P. Simkhada,et al.  Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. , 2008, Journal of advanced nursing.

[28]  M. Kgwete.  Beyond denial—women's dilemmas and choices around HIV-testing, treatment and disclosure , 2008 .

[29]  C. Teasdale,et al.  Enhancing PMTCT programmes through psychosocial support and empowerment of women: The mothers2mothers model of care , 2008 .

[30]  B. Chi,et al.  Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. , 2008, Bulletin of the World Health Organization.

[31]  N. Shaffer,et al.  Factors Associated with Low Early Uptake of a National Program to Prevent Mother to Child Transmission of HIV (PMTCT): Results of a Survey of Mothers and Providers, Botswana, 2003 , 2009, AIDS and Behavior.

[32]  L. Myer,et al.  Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. , 2007, American journal of obstetrics and gynecology.

[33]  M. Cortina-Borja,et al.  Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  S. Bernatsky,et al.  Mental health in HIV-positive pregnant women: Results from Angola , 2007, AIDS care.

[35]  G. Harms,et al.  Risk factors for treatment denial and loss to follow‐up in an antiretroviral treatment cohort in Kenya , 2007, Tropical medicine & international health : TM & IH.

[36]  M. Chersich,et al.  Integration of Antiretroviral Treatment Within Antenatal Care in Gauteng Province, South Africa , 2006, Journal of acquired immune deficiency syndromes.

[37]  H. Doll,et al.  Depression among pregnant rural South African women undergoing HIV testing. , 2006, JAMA.

[38]  K. Peltzer,et al.  Factors influencing the utilisation of prevention of mother-to-child transmission (PMTCT) services by pregnant women in the Eastern Cape, South Africa , 2005 .

[39]  G. Sherman,et al.  Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa , 2005, AIDS care.

[40]  M. Newell,et al.  Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  E. Abrams.  Prevention of mother-to-child transmission of HIV--successes, controversies and critical questions. , 2004, AIDS reviews.

[42]  T. Einarson,et al.  Prevalence of Depression During Pregnancy: Systematic Review , 2004, Obstetrics and gynecology.

[43]  C. Garcia-Moreno,et al.  Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. , 2004, Bulletin of the World Health Organization.

[44]  B. Rapkin,et al.  Psychosocial Factors Associated with Adaptation in HIV-Infected Mothers , 2000, AIDS and Behavior.

[45]  L. Myer,et al.  Why do women seek antenatal care late? Perspectives from rural South Africa. , 2003, Journal of midwifery & women's health.

[46]  M. Kwalombota.  The effect of pregnancy in HIV-infected women , 2002, AIDS care.

[47]  M. E. James.  HIV seropositivity diagnosed during pregnancy: psychosocial characterization of patients and their adaptation. , 1988, General hospital psychiatry.